Breaking News

XOMA Earns $10M Milestone

Licensed asset advances into clinical development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

XOMA Corp. has earned a $10 million milestone payment for the clinical advancement of an asset licensed to one of its pharmaceutical partners. Specific details were not disclosed. “Our corporate strategy is to drive shareholder value by combining revenue from our portfolio of collaborator-funded programs with a lean cost structure,” stated Jim Neal, Chief Executive Officer of XOMA. “This $10 million milestone payment is the first of a potential $40 million we could receive from our portfolio ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters